Literature DB >> 10497102

Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection.

M C Jung1, B Hartmann, J T Gerlach, H Diepolder, R Gruber, W Schraut, N Grüner, R Zachoval, R Hoffmann, T Santantonio, M Wächtler, G R Pape.   

Abstract

Cytokines that are secreted as a response to viral antigen not only have direct antiviral properties but also crucially influence immune reactions determining the outcome of infection. As an advantageous alternative to the study of cytokines present in the supernatants of antigen-specific T cell clones and lines, we have used ELISPOT assays to determine the number of interferon-gamma (IFN-gamma)- and IL4-producing cells generated by peripheral blood mononuclear cells from patients with acute hepatitis B (AHB) and chronic hepatitis B (CHB) infection in response to HBcAg in a short-term culture (48 h). In response to HBcAg IFN-gamma was predominantly produced. In contrast to the results obtained in acute hepatitis B, the typical lymphokine pattern in CHB was characterized by a weak or absent antigen-specific IFN-gamma production. A predominance of IL-4-producing cells was not observed in either AHB or CHB. A significant number of IFN-gamma-producing cells was usually detectable during phases of viral elimination and the quality of the lymphokine response seemed to be epitope independent. Comparison of the results obtained in proliferation assays and ELISPOT assays clearly shows that lymphokine production upon stimulation with viral protein is totally independent of T cell proliferation and more sensitively reflects antiviral reactivity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497102     DOI: 10.1006/viro.1999.9833

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.

Authors:  Ji Chen; Yan Wang; Xue-Jie Wu; Jun Li; Feng-Qin Hou; Gui-Qiang Wang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.

Authors:  M Shi; S Qian; W-W Chen; H Zhang; B Zhang; Z-R Tang; Z Zhang; F-S Wang
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

3.  CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.

Authors:  E Malanchère-Brès; P J Payette; M Mancini; P Tiollais; H L Davis; M L Michel
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users.

Authors:  Jianrong Li; Jing Wang; Kunlun Tian; Yixin Wang; Lei Zhang; Hanju Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  Immunomodulation therapy in children with chronic hepatitis B.

Authors:  Murat Karaoglan; Fikret Demirci; Yavuz Coskun; Ilkay Karaoglan; Ziya Bayraktaroglu; Vahap Okan; Tekin Karsligil
Journal:  J Natl Med Assoc       Date:  2006-02       Impact factor: 1.798

Review 6.  Natural history of chronic hepatitis B virus infection.

Authors:  Katrin Busch; Robert Thimme
Journal:  Med Microbiol Immunol       Date:  2014-12-25       Impact factor: 3.402

7.  Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.

Authors:  Carolina Boni; Paola Fisicaro; Caterina Valdatta; Barbara Amadei; Paola Di Vincenzo; Tiziana Giuberti; Diletta Laccabue; Alessandro Zerbini; Albertina Cavalli; Gabriele Missale; Antonio Bertoletti; Carlo Ferrari
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

8.  Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.

Authors:  Anthony Tanoto Tan; Elisabetta Loggi; Carolina Boni; Adeline Chia; Adam J Gehring; Konduru S R Sastry; Vera Goh; Paola Fisicaro; Pietro Andreone; Christian Brander; Seng Gee Lim; Carlo Ferrari; Florian Bihl; Antonio Bertoletti
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

9.  Ribavirin and IFN-alpha combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B.

Authors:  Fen-Yu Ren; Hai Jin; Xi-Xu Piao; Feng-Shun Piao
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

10.  Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.

Authors:  James S Testa; Ramila Philip
Journal:  Future Virol       Date:  2012-11-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.